Purpose: To quantitatively analyze in vivo morphology of subfoveal choroid during an acute attack of Behçet uveitis.
O cular involvement of Behçet disease is characterized by bilateral nongranulomatous panuveitis with retinal vasculitis. Diffuse vitritis, occlusive retinal vasculitis, retinal infiltrations, cystoid macular edema, and optic nerve head inflammation are the typical signs of active inflammation in the posterior segment of the eye. Recurrent inflammatory attacks of variable severity involving the posterior segment determine the visual prognosis. 1 Therefore, the activity and severity of ocular involvement and the efficacy of therapy need to be closely monitored. Since retinal vasculature is predominantly involved in Behçet disease, fluorescein angiography (FA) is the gold standard imaging modality to detect and monitor the extent of posterior segment inflammatory activity. 2, 3 As Behçet disease is a systemic vasculitis, it might be expected to lead to primary involvement of the choroid vessels as well. Choroidal inflammation may also develop secondary to severe retinal inflammation. Choroidal involvement in Behçet uveitis has been implicated based on histopathology, indocyanine green angiography (ICGA), and ophthalmic ultrasonography findings. Histopathologic studies have shown diffuse and focal infiltration of the choroid with lymphocytes and macrophages. [4] [5] [6] Presence of hypoand hyperfluorescent spots, irregular filling of choriocapillaris, choroidal filling defects, staining of and leakage from choroidal vessels, and optic disk and diffuse choroidal hyperfluorescence in the intermediate or late phase of ICGA were reported as ICGA signs suggestive of choroidal involvement in Behçet disease. [7] [8] [9] [10] [11] Ophthalmic ultrasonography revealed choroidal thickening in eyes with Behçet uveitis; however, because of its low resolution, ultrasonography lacks detailed information. 12, 13 Although these studies suggest choroidal vasculitis, choroidal involvement is not clinically evident in Behçet uveitis.
Enhanced depth imaging optical coherence tomography (EDI OCT), already integrated into most commercially available optical coherence tomography (OCT) machines, provides in vivo, cross-sectional, histologic information of the choroid including choroidal thickness measurements and imaging of choroidal structure. 14 At present, there are four publications reporting on choroidal thickness analysis by EDI OCT in patients with Behçet uveitis. [15] [16] [17] [18] Their outcomes are conflicting as three studies report thickening of the choroid [15] [16] [17] and one suggests thinning of the choroid in patients with Behçet uveitis. 18 The discrepancies in choroidal thickness are likely because of nonhomogenous patient recruitment in terms of activity, anatomical involvement, and duration of Behçet uveitis.
We herein evaluated in vivo quantitative morphology of subfoveal choroid and choroidal thickness using EDI OCT in patients with an acute attack of Behçet uveitis, and compared with age-, sex-, and spherical equivalent of refractive error-matched healthy subjects. A novel custom software was used to segment the choroidal into stroma and vessel lumen. Furthermore, we assessed the intercorrelations between the EDI OCT choroidal parameters and ICGA and FA findings, visual acuity, clinical composite score of uveitis attack severity, anterior chamber flare, and central foveal thickness (CFT) measurement.
Materials and Methods
This prospective cross-sectional study was approved by the institutional review board of Koc University (approval number: 2014.197.IRB1.011). All patients were white and of Turkish descent. The study was conducted according to the tenets of the Declaration of Helsinki and an informed consent was obtained from the patients.
Patient and Control Subject Recruitment
Twenty-eight consecutive Behçet disease patients who attended two tertiary referral uveitis clinics and deemed to have an acute uveitis attack involving the posterior segment of the eye by two observers (ITT and SO) were included from May 1, 2015 to March 30, 2016 . Uveitis attack involving the posterior segment was defined as an increase in or the development of vitreous haze, the emergence of inflammatory sheathing of retinal vessels, vascular occlusion, retinal hemorrhages, retinal infiltrates, macular edema, and/or papillitis.
Exclusion criteria were a duration of Behçet uveitis for more than 4 years, eyes with spherical equivalent refractive error of more than ±5.00 diopters, eyes with visually significant cataract or media opacity obscuring precise visualization of the choroidoscleral interface, eyes with concurrent ocular disease, patients with a comorbidity such as diabetes mellitus, systemic hypertension or other coexistent autoimmune disease, eyes with a history of ocular surgery and/or intravitreal injection/implant, patients with a history of refractive surgery, and patients aged 18 years or younger, and patients aged 50 years or older.
Age-, sex-, and spherical equivalent of refractive error-matched healthy subjects were recruited from consecutive patients who were scheduled for routine ocular examination for refractive error correction at the Koc University Hospital.
Ocular Examination
All patients underwent a complete ophthalmologic examination, including best-corrected visual acuity, slitlamp biomicroscopy, tonometry, and indirect ophthalmoscopy. A decimal scale Snellen chart and equipment that yielded each patient's best refractive correction were used to determine visual acuity. Visual acuities were converted to logarithm of minimum angle of resolution scale. Laser flare photometer (KOWAFC-2000; KowaCo Ltd, Tokyo, Japan) was used to measure anterior chamber flare in patients seen at the Istanbul Faculty of Medicine.
Uveitis Attack Severity Scoring
The severity of uveitis attack was scored for each eye based on the Behçet disease ocular attack score 24 (BOS24) developed by Kaburaki et al. 19 It consists of a total 24 points summarized from 6 parameters of ocular inflammatory signs, including anterior chamber cells (0-4), vitreous haze (0-4), peripheral fundus lesions (0, 2, 4, 6, 8), posterior pole lesions (0, 2, 3, 4), foveal lesions (0, 2), and optic disk lesions (0, 2).
Scoring of Anterior Chamber Cells and Vitreous Haze
Cells in the anterior chamber are graded from 0 to 4 using a semiquantitative scoring system. Vitreous haze is also graded using a semiquantitative scoring system based on the clarity of the optic disk, retinal vessels, and nerve fiber layers, and is graded from 0 to 4. Both anterior chamber cells and vitreous haze grades are based on the standardization of uveitis nomenclature working group grading. 20 
Scoring of Retinal Inflammatory Signs
The retina is divided into peripheral retina (areas outside of arcade vessels) and posterior pole (areas inside of arcade vessels). Peripheral retina is further divided into four quadrants by a horizontal and vertical line passing through the fovea. When scoring the peripheral retina, two points are added for each quadrant with new inflammatory signs, that is, any new retinal exudates or hemorrhages. Retinal edema is not scored in the absence of other findings. When scoring the posterior pole of the retina, the percentage of the area of new inflammatory signs (hemorrhages, exudates) occupying areas of the posterior pole is determined. If the percentage of area of new inflammatory signs is less than 10%, 2 points; if the percentage is 10% or more and less than 25%, 3 points; and if the percentage is 25% or more, 4 points are assigned.
Scoring of Foveal and Optic Disk Lesions
For any new hemorrhages or exudates observed in the fovea, two points are added as foveal lesion score. If there are new inflammatory signs of the optic disk (redness and edema, sometimes accompanied by hemorrhages, exudates, retinal edema surrounding the optic disk) two points are added as the optic disk lesion score.
In patients with bilateral activation, the eye with a higher BOS24 score was selected as the study eye; if both eyes had identical BOS24 scores, one eye was randomly assigned for analysis. The eye of control subjects was selected based on the laterality of the study eye of the patients. All imaging procedures described below were done on the same day as the uveitis attack scoring.
Optical Coherence Tomography Scanning Procedures and Subfoveal Choroidal Thickness and Central Foveal Thickness Measurements
Examinations were accomplished by the Heidelberg Spectralis spectral-domain optical coherence tomography device (Heidelberg Engineering, Heidelberg, Germany) with software version 6.0, and after pupillary dilation using tropicamide 1% and phenylephrine hydrochloride 2.5%. To avoid diurnal variations, measurements were performed at around noon. The Spectralis device contains an 870-nm wavelength superluminescent diode laser and is capable of obtaining 40,000 A-scans per second.
Following the guidelines of the Spectralis user manual, the subjects' keratometry readings and the most recent refraction were entered into the software program to estimate optical magnification and, therefore, to allow for more accurate comparisons across individuals. The spherical equivalent of refractive error was calculated as the sphere plus half a cylinder. Results from manifest refraction were used for analysis. Choroidal thickness was defined as the distance from the outer border of the hyperreflective retinal pigment epithelium perpendicular to the choroidoscleral interface.
The built-in EDI OCT feature in the Heidelberg software was used to evaluate the choroid. The scan patterns consisted of 2 single line scans obtained horizontally and vertically, and one cross-hair scan within 5 · 30°of fixation averaged for 100 scans using the automatic averaging and eye-tracking features. One horizontal and one vertical scan with the best image quality (Q-factor) were selected from the different scan patterns for evaluation. Images with a Q-factor less than 25 were not included for analysis. Images were captured with the high-speed acquisition mode and have a digital resolution of 3.9 mm axially · 11 mm laterally.
Using digital calipers provided by the Heidelberg Spectralis OCT software, choroidal thickness was measured manually at 5 locations: at the fovea and at 750 mm nasal, temporal, superior, and inferior to the fovea. To avoid possible overestimation of choroidal thickness in measurements based on 1:1 pixel image, measurements were performed using 1:1 mm images. Two experienced independent observers (SO, GU) blind to each other's readings measured subfoveal choroidal thicknesses, measurements were averaged for analysis. A magnification of at least 100% to 200% was used to place the measurement line precisely. The observers were also allowed to adjust the contrast of the image to better delineate choroidal boundaries. However, measurements were not taken in eyes or at locations where the posterior border of the choroid was poorly demarcated despite the procedures described above.
One 25-line raster spectral-domain optical coherence tomography image with a scan size of 30 · 25°a nd automatic real time set at 25 was obtained and CFT was recorded from the central 1 mm Early Treatment Diabetic Retinopathy Study grid display on the thickness map report.
Light-To-Dark (Choroidal Stroma-To-Choroidal Vessel Lumen) Ratio Calculation A custom software was developed using MATLAB software (The Math Works, Inc, Natick, MA). Optical coherence tomography scans were exported from the OCT acquisition software as grayscale, compressionfree, quality-preserving TIFF images. A region of interest of 1.5 mm width centered below the fovea in the choroid was selected manually (Figure 1 ). Light-todark ratio was calculated according to the threshold levels obtained by Otsu's method. 21, 22 A separate Otsu threshold was determined for each pixel in the region of interest, locally. The threshold determined for a pixel minimizes the intraclass variances of two classes (comprised of pixels below and above the threshold) in a 21 · 21 pixel rectangular region at the center of which the pixel of interest is located. Within the region of interest, a pixel above its local threshold is designated as a light pixel and corresponds to choroidal stroma, whereas a pixel below its local threshold is designated as dark and corresponds to the choroidal vessel lumen. Hence the light-to-dark ratio represents choroidal stroma-tochoroidal vessel lumen (CS:CVL) ratio and will be referenced as such throughout the rest of this paper.
Images were excluded from analysis, in case the observer decided that there was significant noise that could potentially affect the CS:CVL ratio.
Dual Fluorescein and Indocyanine Green Angiography Scoring
Dual FA and ICGA images were obtained from the posterior pole and eight peripheral sweeps at early (0-5 minutes), intermediate (8-12 minutes) , and late (25-30 minutes) phases using the Heidelberg retinal angiograph 2 (Heidelberg Engineering, Heidelberg, Germany) after an intravenous injection of 2.5 mL of 10% sodium fluorescein (Fluorescite; Alcon, Inc, Fort Worth, TX) and 2.5 mL of 5 mg/mL indocyanine green (ICG-Pulsion 25 mg; PULSION Medical Systems SE, Munich, Germany).
An angiographic scoring system developed by the Angiography Scoring for Uveitis Working Group and with proven interobserver reliability was used for scoring of FA and ICGA. [23] [24] [25] [26] All angiograms were scored by one experienced ophthalmologist (CPH) who was blind to the clinical findings of the patients.
The angiographic scoring system used herein is a semiquantitative system. 23 The fundus is divided into four quadrants by a horizontal and a vertical line passing through the optic disk. The area between the temporal vascular arcades is defined as the posterior pole. Fluorescein angiography signs include nine categories. Optic disk hyperfluorescence is graded from 0 (normal) to 3 (1 = partial staining, 2 = diffuse staining, and 3 = leakage with blurring of disk margins and papillary vasculature). Macular edema is graded from 1 (faint hyperfluorescence) to 4 (pooling of dye in cystic spaces). Retinal vascular staining and/or leakage are scored separately according to their location. Retinal vascular staining and/or leakage of posterior pole arcades are scored as focal (score of 1), more extended or multifocal, but limited in area (score of 2), or diffuse (score of 3). Involvement of other parts of the retinal vascular tree is graded only as either absent (score of 0) or present (score of 1). Capillary leakage is scored separately for the posterior pole (excluding perifoveal ring of leakage) and for each quadrant. Capillary leakage of the posterior pole is scored as limited (score of 1) or diffuse (score of 2). For each quadrant, foci of leakage limited in area or intensity is scored as 1, and diffuse leakage is scored as 2. Retinal capillary nonperfusion is graded according to the number of quadrants in which it is present. Any area of capillary nonperfusion in the macula (enlargement of foveal avascular zone), posterior pole (excluding macular ischemia), and in each quadrant is given an additional score of 1. Neovascularization of disk is assigned a score of 2. Neovascularization elsewhere is graded with a score of 1 for neovascularization elsewhere at one focus and with a score of 2 for multiple foci. Pinpoint leak is graded as localized if present in three or less disk diameters (score of 1), or extensive if present in more than three disk diameters (score of 2). Retinal staining and/or subretinal pooling are graded as localized if present in three or less disk diameters (score of 1), or extensive if present in more than three disk diameters (score of 4). The maximum score for each angiographic sign is 3 for optic disk hyperfluorescence, 4 for macular edema and retinal staining/subretinal pooling, 7 for retinal vascular staining/leakage, 10 for capillary leakage, 6 for retinal capillary nonperfusion, and 2 for neovascularization of disk, neovascularization elsewhere, and pinpoint leaks. Hence, the total maximum score for a given eye might be 40. Total FA score, retinal vascular staining and/or leakage score, and capillary leakage score were used for correlation analyses in this study.
Based on the angiographic scoring system, ICGA signs include four categories. 23 Early stromal vessel hyperfluorescence is graded separately for the posterior pole and retinal quadrants. A score of 1 is given if it is present in the posterior pole. It is scored as 1 if it is present in one to two quadrants, and as 2 if it is present in more than two quadrants. Choroidal vasculitis (fuzzy choroidal vessels) is categorized as faint (course recognizable, score of 1); as moderate (vessels more blurred but course recognizable) which is further graded as localized/limited if it encompasses one to two quadrants (score of 2), and as diffuse if it encompasses more than two quadrants (score of 3); and as fuzzy vessels without recognizable course, and is graded as localized/limited if it encompasses one to two quadrants (score of 4), and as diffuse if it encompasses more than two quadrants (score of 6). Dark dots/areas (excluding atrophy) are graded separately according to their location. Dark dots/areas of posterior pole are graded as sparse and/or faint (score of 1) or as numerous and/or pronounced (score of 2). Involvement for each quadrant is graded as sparse and/or faint (score of 1), or as numerous and/or pronounced (score of 1.5). Optic disk hyperfluorescence is graded as perceptible (score of 1) or as pronounced (score of 3). The maximum score for each angiographic sign is 3 for early stromal vessel and optic disk hyperfluorescence, 6 for choroidal vasculitis, and 8 for dark dots. The total maximum ICGA score might be 20 for a given eye. Total ICGA score was used for correlation analyses.
Statistical Analysis
Statistical evaluation SPSS 21.0 software was used for statistical analysis (SPSS Inc, Chicago, IL). Interobserver agreement was calculated using intraclass correlation coefficient and 95% confidence intervals. For group comparisons Mann-Whitney U test was used. Association of ocular clinical parameters was assessed using Spearman's coefficient of correlation. A correlation coefficient of 0.1 to 0.3 was considered as weak correlation, 0.4 to 0.6 as moderate correlation, 0.7 to 0.9 as strong correlation, and 1.0 of perfect correlation as suggested by Dancey and Reidy. 27 Diagnostic sensitivity and specificity and cutoff values were determined using a receiver operating characteristic curve and area under the receiver operating characteristic curve (AUC) analysis. The receiver operating characteristic curve is a useful method to represent the ability of tests or parameters to differentiate between normal and pathologic subjects. In a receiver operating characteristic curve, the true-positive rate (sensitivity) is designed as a function of the false-positive rate (1-specificity) for different cutoff points of a parameter. The resulting AUC indicates how well a parameter can distinguish between the examined groups: control or diseased. The interpretation for AUC is as follows: no discrimination if AUC is #0.5, acceptable discrimination if AUC is $0.7 to 0.8, excellent discrimination if AUC is $0.8 to 0.9, and outstanding discrimination if AUC is $0.9. 28 A P value less than 0.05 was considered statistically significant. 
Results
All patients had bilateral active disease. Twentyeight eyes of 28 patients (mean age, 29.75 ± 7.31 years; mean spherical equivalent, 20.22 ± 1.00 diopters) with an acute attack of Behçet uveitis were included in the study. Table 1 shows demographic features, refractive error, and logarithm of minimum angle of resolution visual acuity in the patient and control groups; as well as anterior chamber flare values, disease duration, and attack duration in the patient group. There were no significant differences in gender, age, and spherical equivalent of refractive error between the two groups. The duration of Behçet uveitis was 4 years or less in all patients. The median Behçet uveitis duration was 18 months (range: 1-48 months). Median interval between onset of symptoms of a uveitis attack and enrollment was 7 days (range: 1-15 days).
The BOS24, FA, and ICGA scores of 28 eyes with active Behçet uveitis are shown in Table 2 . Mean total BOS24, FA, and ICGA scores were 7.42 ± 4.10 (range: 2-18), 17.42 ± 6.03 (range: 3-27), and 0.66 ± 0.73 (range: 0-2), respectively. Total ICGA scores were generally very low and 13 eyes (46.4%) had a total score of zero. The median total FA score was 14 (range: 3-25) in these 13 eyes. Table 3 shows OCT measurements including CS: CVL ratio, subfoveal choroidal thickness, and CFT in patients and controls. The CS:CVL ratio was significantly higher in eyes with active Behçet uveitis (0.413 ± 0.056) indicating choroidal stromal expansion when compared with the control group (0.351 ± 0.063), (P = 0.003). There were no significant differences between patients with active Behçet uveitis and control subjects in subfoveal choroidal thickness measurements. A good interobserver agreement on subfoveal choroidal thickness measurements was obtained, intraclass correlation coefficients and 95% confidence intervals for 5 subfoveal measurement locations are shown in Table 3 . There was a significant increase in CFT in eyes with Behçet uveitis indicating macular edema during the acute attack (352.750 ± 107.134 mm vs. 263.500 ± 20.819 mm, P , 0.001). We also calculated study parameters in fellow eyes of patients with active Behçet uveitis (see Table, Supplemental Digital Content 1, which shows results in the fellow eyes; http://links.lww.com/IAE/A623). Figure 2 exemplifies imaging and measurements of the study eye in one representative patient.
As shown in Table 4 , there were significant correlations between total FA score and logarithm of minimum angle of resolution visual acuity, BOS24 score, anterior chamber flare, total ICGA score and CFT measurements in eyes with active Behçet uveitis. A weak but significant correlation was also observed between the CS:CVL ratio and the retinal vascular staining and/or leakage score of FA (P = 0.036). Interestingly, CFT was identified as an imaging parameter exhibiting significant correlations with logarithm of minimum angle of resolution vision, BOS24 score, total FA score, retinal vascular staining and/or leakage and capillary leakage scores of FA, and total ICGA score.
In order to understand the diagnostic value of CFT in predicting the presence of active intraocular inflammation in early Behçet uveitis we calculated a receiver operating characteristic curve (Figure 3) . The AUC was 0.902 (95% CI = 0.826-0.978, P , 0.001). At a cutoff value of 275 mm or greater the diagnostic sensitivity and specificity of CFT for acute Behçet uveitis were 89% and 72%, respectively.
To further understand the relationship of CS:CVL ratio with disease activity we calculated CS:CVL ratio in 9 study eyes of 3 female and 6 male patients who presented for follow-up from October 15 to November 15, 2016 and were identified to have remission of Behçet uveitis following initiation or augmentation of immunomodulatory therapy. The mean interval between the 2 examinations was 13.88 ± 4.26 months. There was a significant decrease in BOS24 score (6.55 ± 4.58 vs. 0.88 ± 1.05, P = 0.007), total FA score (12.55 ± 4.24 vs. 2.55 ± 2.60, P = 0.008), and CFT (348.555 ± 141.162 mm vs. 275.666 ± 21.965 mm, P = 0.028) during remission of Behçet uveitis. We also observed a decline in CS:CVL ratio (0.432 ± 0.066 vs. 0.383 ± 0.047, P = 0.161) during remission, however, it did not reach statistical significance. 
Discussion
This study demonstrated an increased CS:CVL ratio without significant thickening of the choroid in patients with an acute attack of Behçet uveitis at an early stage of the disease. While expansion of the choroidal stroma did not significantly correlate with ICGA and only weakly correlated with vascular staining and/or leakage on FA, CFT on OCT significantly correlated with visual acuity, severity of uveitis attack, FA, and ICGA scores. Table 5 summarizes comparison of publications reporting on choroidal thickness analysis by EDI OCT in patients with Behçet uveitis and the present study. Two studies reported that subfoveal choroidal thickness was significantly greater during an acute attack of Behçet uveitis than in remission. 15, 16 The choroid was also thicker than that of healthy control subjects, not only during an attack of Behçet uveitis, but also during remission of the disease. 16 Another study reported a similar result when they compared eyes in remission of Behçet uveitis with control subjects and found a thicker choroid, although the difference did not reach statistical significance. 17 In contrast, a fourth study demonstrated that the choroid was significantly thinner in eyes of Behçet patients with active posterior uveitis in comparison to control subjects. 18 There was no significant difference in the choroidal thickness between eyes with an acute attack of Behçet uveitis and those in remission. 18 The results of these studies are conflicting because of the nonhomogenous patient populations studied, based on variable definition of activity and remission, anatomical involvement of uveitis, and disease duration. In order to avoid such bias, we included only patients with a duration of Behçet uveitis for 4 years or less, that is, patients with an early disease. It is known that Behçet uveitis is most active during the first 2 to 3 years, and that this period of time is critical for visual prognosis. [29] [30] [31] [32] Therefore, we determined a disease duration of #4 years as an inclusion criterion. We also recruited only those patients with an acute attack of Behçet uveitis involving the posterior segment of the eye. Our study is not limited to choroidal thickness measurements as previous ones and involves quantitative segmentation of the choroid into choroidal stroma and choroidal vessel lumen through binarization of the EDI OCT images using the Otsu threshold.
Fluorescein angiography and ICGA are both invasive tests that require intravenous administration of dye and imaging up to 10 to 30 minutes. [33] [34] [35] [36] [37] In Behçet uveitis, choroidal thickness measured by EDI OCT has been proposed as a noninvasive parameter for assessment of disease activity and the response to therapy. 15, 16 Although it is noninvasive, choroidal thickness measurement on EDI OCT imaging has pitfalls. Current software in commercially available OCT devices cannot automatically calculate subfoveal choroidal thickness, manual measurements are tedious and time consuming, and delineating the choroidoscleral interface in subjects with a thick choroid is difficult. As opposed to previous studies, we were not able to demonstrate any significant thickening or thinning of the choroid during an acute attack of Behçet uveitis in patients at an early stage of the disease. However, we observed a significant correlation between CFT and visual acuity, uveitis attack severity score (BOS24 score), total FA score, and FA signs assessing retinal vascular leakage and total ICGA score. Area under the receiver operating characteristic curve for CFT was calculated as 0.902 indicating outstanding discrimination. At a cutoff value of 275 mm diagnostic sensitivity and specificity of CFT for acute Behçet uveitis were 89% and 72%, respectively. Therefore, we propose CFT, an automatically calculated parameter, but not choroidal thickness measurement on EDI OCT, for noninvasive monitoring of inflammatory activity in early Behçet uveitis. In patients with advanced disease and diffuse macular atrophy, CFT may not be a useful measure of inflammatory activity, but could serve as a measure of damage. Takeuchi et al have reported a significant correlation between duration of Behçet uveitis and retinal thinning at the fovea. 38 Despite the presence of a significant correlation between the total FA score and FA subscores assessing retinal vascular leakage and the total ICGA score, ICGA was not able to show any significant inflammatory activity in the choroid as the median total score was 1 and maximum score was 2 (on a 0-20 scale). In fact, 46.4% of eyes had a total score of zero on ICGA in our study, while FA showed scores up to 25 in these eyes. Although ICGA suggested vascular involvement in previous studies, ICGA findings reported up to date are not specific for Behçet uveitis. [7] [8] [9] [10] [11] Therefore, use of ICGA has not been recommended on a routine basis in patients with Behçet uveitis. 2, 3, 10 The results of this study are in agreement with previous reports.
An important finding of this study was the occurrence of choroidal stromal expansion in eyes with active Behçet uveitis evidenced upon segmentation of the choroid into choroidal stroma and choroidal vessel lumen using custom software. Patients with Behçet uveitis had a significantly higher CS:CVL ratio when compared with control subjects. However, choroidal stromal expansion was not associated with thickening of the choroid, as we were not able to show any significant thickening of the subfoveal choroid in patients with an acute attack of Behçet uveitis. It has been suggested that inflammatory cells start to accumulate in the inner choroidal stroma because blood vessels in Sattler's layer have thinner walls compared with the larger vessels in Haller's layer. 39 We hypothesize that the choroidal inflammatory infiltration in patients with active Behçet uveitis apparent upon CS:CVL ratio analysis might be related to this fact. It has also been suggested that inflammatory conditions that primarily affect the inner choroid are less likely to cause thickening of the whole choroid. 40 Based on our results, we speculate that the inner choroidal vessels may be predominantly involved in Behçet disease. This may be of primary nature or secondary to the neighboring retinal inflammation.
To date, there is very limited information on segmentation of the choroid into stroma and vessel lumen on EDI OCT images. Branchini et al first calculated CS: CVL ratio in normal eyes using Otsu threshold and MATLAB software. 22 Kawano et al 41 segmented the choroid using Niblack threshold and imageJ software in eyes with Vogt-Koyanagi-Harada disease. The authors analyzed choroidal changes induced by high-dose systemic corticosteroid treatment. As expected, choroidal thickness was significantly reduced from 678.8 ± 150.2 mm at baseline to 363.3 ± 74.3 mm at 1 week and 307.8 ± 61.3 mm at 1 month. Luminal area-tochoroidal area ratio was 0.60 ± 0.03 at baseline, 0.67 ± 0.04 at 1 week, and 0.66 ± 0.04 at 1 month. There was a significant increase from the baseline at 1 week but not from 1 week to 1 month. This finding implies that there is massive stromal infiltration with compression of vessels and thickening of the choroid during the acute phase of Vogt-Koyanagi-Harada disease which responds favorably to therapy. Because massive inflammatory infiltration of the choroid occurs in patients with Vogt-Koyanagi-Harada disease, choroidal changes are striking, as opposed to patients with Behçet uveitis where no such robust changes occur in the choroid.
Our study group was biased by the inclusion of patients where imaging of the posterior segment could 42 Therefore, swept-source OCT may serve as a superior tool in revealing pathological changes in the choroid in patients with severe intraocular inflammation. We believe that advances in OCT angiography will also provide information on choroidal vascular alterations in Behçet uveitis.
In conclusion, we demonstrated that there was no significant change in the subfoveal choroidal thickness as measured by EDI OCT in a homogenous group of patients who had 4 years or less of disease duration, and had an acute posterior attack of Behçet uveitis. However, there was a significant change in the choroidal stroma-to-vessel lumen ratio which was not associated with a thickening in the subfoveal choroid. We assume that this might be related to inner stromal involvement in Behçet uveitis. Our results support the fact that FA remains the gold standard in monitoring inflammation in Behçet uveitis. Indocyanine green angiography was nonrewarding in assessing the extent of choroidal inflammation. Central foveal thickness may be used as a noninvasive measure to assess the inflammatory activity in patients with early Behçet uveitis.
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